Study shows calcium, Vitamin D have neutral effect on postmenopausal women’s blood pressure
NEW YORK A seven-year research study published in the November issue of the journal Hypertension that evaluated supplementation with calcium and vitamin D and its effect in helping to prevent high blood pressure in older, postmenopausal women determined that the two supplements combined neither had a positive nor negative effect on blood pressure, according to a Reuters Health report published Thursday.
“Shortcuts with dietary supplements cannot be substituted for encouraging people to adopt dietary patterns that have been shown to lower blood pressure and decrease the risk of hypertension,” stated lead researcher Karen Margolis, of HealthPartners Research Foundation.
As part of the Women’s Health Initiative, the research team studied the effects of 1,000 mg of calcium plus 400 international units vitamin D3, or placebo, in women 50 to 79 years of age. There were 18,000 women in each study group.
After an average follow-up of seven years, there was no significant difference between groups in the change in blood pressure, or in the number of women who developed hypertension or prehypertension.
FDA announces recall of Tyco ReliOn single-use syringes
ROCKVILLE, Md. Food and Drug Administration said Wednesday that Tyco Healthcare Group is recalling a lot of its ReliOn single-use syringes for diabetics.
The recall affects lot number 813900, which contines 100 31-gauge ReliOn hypodermic syringes containing 1 milliliter of U-100 insulin. Tyco distributed 4,710 boxes in the recalled lot, totaling 471,000 individual syringes. Wal-Mart sold the syringes at its stores between Aug. 1 and Oct. 8, and Tyco voluntarily recalled the lot Oct. 9. Wal-Mart has sent letters to 16,500 customers notifying them of the recall and posted an announcement on its Web site.
Can-Am Care distributes the syringes and sells them through Wal-Mart and Sam?s Club stores under the Reli-On brand. The mass-merchandiser has requested that all users of this type of syringe return those that come from the recalled lot.
The FDA said that during the packaging of the syringes, some syringes labeled for use with U-40 insulin were mixed with syringes labeled for use with U-100 insulin and then packaged individually and in boxes as 100 units for use with U-100 insulin. Tyco has received one report of complications due to use of a syringe from the recalled lot.
Medical information leaks prompt added awareness about records security
CHICAGO News reports about high-profile victims of personal medical information security and privacy breaches highlight the need to educate and inform healthcare professionals, their employees, the media and consumers on privacy protection, an professional organization for the health information management industry said Thursday.
The American Health Information Management Association said that educating healthcare professionals on privacy and security issues is an ongoing concern within the health information industry.
“It’s critical for healthcare professionals to receive more education about good privacy practices and appropriate interpretation of HIPAA and other regulations,” AHIMA president Wendy Mangin said.